Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 08 Nov 2013 for Allergan plc, €1.3M.
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
No signal scores available.
Charles D. Ebert: trading record in brief
Charles D. Ebert has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Watson Pharmaceuticals Inc and Allergan plc. Over a trading history stretching from 1 September 2006 to 6 November 2013, the count stands at 55 filings.
The open-market record consists of 14 sales worth €4.2M, with no purchase. The rest of the record consists of 26 share grants and 14 option exercises. In 2013 alone, the filings show no purchases and 2 sales.
On 8 November 2013 came the latest disclosure, an open-market sale for €1.3M in Allergan plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Charles D. Ebert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
10,877 shares@ US$158.75Ordinary SharesSEC:0001179110-13-016337:0
18,488 sharesOrdinary SharesSEC:0001179110-13-015197:0
12,212 sharesCommon Stock, par value $0.0033SEC:0001179110-13-015052:0
13,694 shares@ US$144.00Common Stock, par value $0.0033SEC:0001179110-13-015052:1
18,488 sharesCommon Stock, par value $0.0033SEC:0001179110-13-015052:2
8,244 shares@ US$136.25Common Stock, par value $0.0033SEC:0001179110-13-013101:0
8,244 shares@ US$136.25Common Stock, par value $0.0033SEC:0001179110-13-012762:0
2,653 shares0Common Stock, par value $0.0033SEC:0001179110-13-004742:0
1,727 shares0Common Stock, par value $0.0033SEC:0001179110-13-004742:1
1,331 shares@ US$86.46Common Stock, par value $0.0033SEC:0001179110-13-004505:0
1,761 shares@ US$85.54Common Stock, par value $0.0033SEC:0001179110-13-004330:0
1,265 shares@ US$59.21Common Stock, par value $0.0033SEC:0001179110-12-005195:0
3,342 shares0Common Stock, par value $0.0033SEC:0001179110-12-004793:0
2,566 shares0Common Stock, par value $0.0033SEC:0001179110-12-004793:1
1,000 shares@ US$25.64Common Stock, par value $0.0033SEC:0001179110-12-003877:0
1,000 shares@ US$58.77Common Stock, par value $0.0033SEC:0001179110-12-003877:1
3,981 shares@ US$58.81Common Stock, par value $0.0033SEC:0001179110-12-003877:2
1,458 shares@ US$58.17Common Stock, par value $0.0033SEC:0001179110-12-003649:0
2,635 shares@ US$64.45Common Stock, par value $0.0033SEC:0001179110-11-009096:0
616 shares@ US$56.89Common Stock, par value $0.0033SEC:0001179110-11-004919:0
1,295 shares@ US$56.79Common Stock, par value $0.0033SEC:0001179110-11-004559:0
7,119 shares0Common Stock, par value $0.0033SEC:0001179110-11-004249:0
7,500 shares@ US$48.85Common Stock, par value $0.0033SEC:0001179110-11-004249:1
7,500 shares@ US$56.36Common Stock, par value $0.0033SEC:0001179110-11-004249:2
3,639 shares@ US$51.00Common Stock, par value $0.0033SEC:0001179110-10-017066:0
25 of 55 declarations
